Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Flinders University trial to evaluate new blood test for personalized cancer treatment

A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway.

1 Jul 2021

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

Nanosized molecules of a particular chemical element can inhibit the formation of plaque in the brain tissues. This new discovery by researchers at Umeå University, Sweden, in collaboration with researchers in Croatia and Lithuania, provides renewed hope for novel treatments of, for instance, Alzheimer's and Parkinson's disease in the long run.

1 Jul 2021

New software tool can help identify gene regulators more efficiently

A team of scientists at the University of Illinois Chicago has developed a software tool that can help researchers more efficiently identify the regulators of genes. The system leverages a machine learning algorithm to predict which transcription factors are most likely to be active in individual cells.

1 Jul 2021

Majority of people were unprepared and did not have a pandemic plan, survey reveals

Researchers point out that if these healthy individuals had a challenging time absorbing COVID-related information, then such challenges may be even greater in people with limited educational opportunities or with neurocognitive disorders, such as Alzheimer's disease or a brain injury, due to low health literacy and impaired memory.

1 Jul 2021

New research receives $2 million grant to determine if meningitis, sepsis increase Alzheimer's risk

The role of peripheral and brain infections in the development of Alzheimer's disease is the focus of new research at The University of Texas Health Science Center at Houston, funded with a $2 million grant from the National Institutes of Health.

30 Jun 2021

Researchers launch a new smell training device for rehabilitation after Covid-19

Smell training used to be mainly a thing for wine enthusiasts, gourmets, and perfumers. But Covid-19 changed all that, and now Malmö University researchers have launched a new smell training device.

30 Jun 2021

Desperate for home care, seniors often wait months with workers in short supply

For years, Louise Shackett has had trouble walking or standing for long periods, making it difficult for her to clean her house in southeastern Maine or do laundry. Shackett, 80, no longer drives, which makes it hard to get to the grocery store or doctor.

30 Jun 2021

Promising preclinical results of new dementia treatment candidate set the stage for human trials

Researchers have identified a new treatment candidate that appears to not only halt neurodegenerative symptoms in mouse models of dementia and Alzheimer's disease, but also reverse the effects of the disorders.

29 Jun 2021

LSL60101 compound improves cognitive deficit in murine models with Alzheimer’s

The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.

29 Jun 2021

IU School of Medicine wins $30 million NIA funding to study Alzheimer’s disease and related dementias

National Centralized Repository for Alzheimer's Disease and Related Dementias grant has been renewed for another five years with funding expected to total $30 million from the National Institute on Aging (NIA), within the National Institutes of the Health.

29 Jun 2021

Advanced X-ray technology provides a viable pipeline for multiscale whole brain imaging

Researchers at the University of Chicago and the U.S. Department of Energy's (DOE) Argonne National Laboratory have leveraged existing advanced X-ray microscopy techniques to bridge the gap between MRI (magnetic resonance imaging) and electron microscopy imaging, providing a viable pipeline for multiscale whole brain imaging within the same brain.

29 Jun 2021

FDA's controversial decision to approve aducanumab for Alzheimer's treatment raises major ethical issues

The U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at least three major ethical issues that need to be addressed, states a new article in the Hastings Center Report:

29 Jun 2021

Alternative model of Alzheimer's emphasizes different set of mechanisms that lead to neurodegeneration

In the context of recent debate over the FDA's approval of aducanumab, it's refreshing to learn about a model of Alzheimer's neurodegeneration that doesn't start with the pathogenic proteins amyloid or Tau.

29 Jun 2021

New study reveals how heparan sulfate promotes amyloid deposition in various organs

Amyloid diseases, including Alzheimer's, Parkinson's, type-2 diabetes and other life-threatening diseases, involve pathologic deposits of normally soluble proteins or peptides as insoluble amyloid fibrils. When this happens in vital organs, such as the brain, kidney, liver and heart, it causes organ damage and, if left untreated, death. Unfortunately, the available treatment options are very limited.

29 Jun 2021

Alzheimer's symptoms could be due to decline in brain protein not accumulation of amyloid plaques

Experts estimate more than 6 million Americans are living with Alzheimer's dementia. But a recent study, led by the University of Cincinnati, sheds new light on the disease and a highly debated new drug therapy.

28 Jun 2021

Scientists develop a simple, noninvasive diagnostic solution for Alzheimer's disease

An international research team led by HKUST has developed a simple but robust blood test from Chinese patient data for early detection and screening of Alzheimer's disease (AD) for the first time, with an accuracy level of over 96%.

28 Jun 2021

Virtual reality can help boost brain rhythms linked to learning and memory

A new discovery in rats shows that the brain responds differently in immersive virtual reality environments versus the real world.

28 Jun 2021

Continuity of nursing care in home health visits may prevent rehospitalization for dementia patients

People with dementia receiving home health care visits are less likely to be readmitted to the hospital when there is consistency in nursing staff, according to a new study by researchers at NYU Rory Meyers College of Nursing.

25 Jun 2021

Differences in human and mouse brain cells have implications for research into neurological disorders

A UCLA-led study comparing brain cells known as astrocytes in humans and mice found that mouse astrocytes are more resilient to oxidative stress, a damaging imbalance that is a mechanism behind many neurological disorders.

25 Jun 2021

New online calculator can predict risk of dementia

Canadian researchers at The Ottawa Hospital, the University of Ottawa, the Bruyère Research Institute and ICES have built and validated an online calculator that empowers individuals 55 and over to better understand the health of their brain and how they can reduce their risk of being diagnosed with dementia in the next five years.

25 Jun 2021

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Flinders University trial to evaluate new blood test for personalized cancer treatment

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

New software tool can help identify gene regulators more efficiently

Majority of people were unprepared and did not have a pandemic plan, survey reveals

New research receives $2 million grant to determine if meningitis, sepsis increase Alzheimer's risk

Researchers launch a new smell training device for rehabilitation after Covid-19

Desperate for home care, seniors often wait months with workers in short supply

Promising preclinical results of new dementia treatment candidate set the stage for human trials

LSL60101 compound improves cognitive deficit in murine models with Alzheimer’s

IU School of Medicine wins $30 million NIA funding to study Alzheimer’s disease and related dementias

Advanced X-ray technology provides a viable pipeline for multiscale whole brain imaging

FDA's controversial decision to approve aducanumab for Alzheimer's treatment raises major ethical issues

Alternative model of Alzheimer's emphasizes different set of mechanisms that lead to neurodegeneration

New study reveals how heparan sulfate promotes amyloid deposition in various organs

Alzheimer's symptoms could be due to decline in brain protein not accumulation of amyloid plaques

Scientists develop a simple, noninvasive diagnostic solution for Alzheimer's disease

Virtual reality can help boost brain rhythms linked to learning and memory

Continuity of nursing care in home health visits may prevent rehospitalization for dementia patients

Differences in human and mouse brain cells have implications for research into neurological disorders

New online calculator can predict risk of dementia

Aneuro: An Overview of Neuroscience Research eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Aneuro: An Overview of Neuroscience Research eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in